The Journal of Clinical Endocrinology & Metabolism · 1976 · 74 citations · 29 references
MedicineEndocrinologyPhysiologyDiabetologyMetabolic PhysiologyMetabolismCarbohydrate MetabolismDiabetes MellitusMetabolic ClearancePancreatic EndocrinologyDecay Rate EstimationDiabetes Mellitus MetabolismGlucagon ClearanceGlucagon PharmacokineticsGlucagon PhysiologyIn Vivo StudiesMetabolic Clearance RateSubjects
To investigate further the "hyperglucagonaemia" of diabetes mellitus, the metabolic clearance rate (MCR) and acute disappearance time (t1/2) of unlabelled pancreatic glucagon were estimated in 9 normal subjects and 7 insulin-dependent diabetics, using a constant infusion technique. The mean MCR (+/-SE) was similar for both groups (control: 9.0 +/- 0.6; diabetics: 11.4 +/- 1.0 ml/kg/min). The MCR was not influenced by the concentration of glucagon at the time of plateau, and the exogenous hormone appeared to be handled similarly to endogenous glucagon. On the other hand, t1/2 calculated from the fractional decay rate of glucagon from plateau was significantly prolonged in the diabetics (t1/2 6.6 +/- 0.5 min) compared with the control group (t1/2 4.8 +/- 0.2 min, P less than 0.01). Furthermore, there was no correlation between MCR and t1/2, for the control, diabetic, or combined group. It therefore appears that the MCR of glucagon is similar in normal and diabetic subjects. However, since the acute disappearance time (t1/2) of glucagon is not identical in these two groups, it appears that the kinetics of the overall in vivo metabolism of pancreatic glucagon are not similar in diabetic and control subjects.
29
Abnormal Alpha-Cell Function in Diabetes
Walter A. Müller, Gerald R. Faloona, E Aguilar-Parada et al. · New England Journal of Medicine · 1970 · 626 citations
Medicine, Endocrinology, Physiology +14
THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS
RogerH Unger, Lelio Orci · The Lancet · 1975 · 595 citations